PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8281703

Programmed oocyte retrieval.

C Villani·S Gerli
View original source ↗Export metadata ↓

Abstract

Several methods of facilitating the work schedule for in vitro fertilization programs have been proposed. LH-RH agonists offer the possibility of manipulating the day of hCG injection and consequently the day of ovum pick-up. Moreover, after desensitization, follicles are contemporarily stimulated and a higher number of mature oocytes are retrieved. The same objective of follicle synchronization can be obtained with progestins, which have the advantage of minor cost and less adverse effects. The use of oral contraceptives offers similar results to those obtained with progestins. The best choice in work programming appears to be a "monitorized programmed oocyte retrieval" with the use of progestins and LH-RH agonists.

Explore related subjects

Contraceptives, OralFemaleFertilization in VitroGonadotropin-Releasing HormoneHumansOocytesOvulation InductionProgestinsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Villani, S Gerli. 1993. Programmed oocyte retrieval.. https://pubmed.ncbi.nlm.nih.gov/8281703/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Oral contraceptive use and benign gynecologic conditions. A review.

The following review considers the main epidemiologic data on oral contraceptives (OC) and the risk of major benign gynecologic diseases. Earlier studies investigating the relationship between OC use and functional ovarian cysts indicated that the use of high-dose combination OC have a protective effect, whereas low-dose monophasic or multiphasic pills have little or no effect. With regard to seromucinous cysts, the scanty data available are consistent with the notion of some protection of OC in current but not in former users, although possible effects of diagnostic and selection bias should be considered. Published data on the relationship between fibroids and OC appear too scattered to allow a precise quantification of risk. In any case, any relationship is moderate and, hence, of limited clinical and public health relevance. The data on OC and benign gynecologic conditions are reassuring in their absence of any consistent excess risk.

Contraceptives, Oral↗